These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 14464270)

  • 1. 5-Hydroxytryptamine levels in brain of mice pretreated with Alpha-methyl-dopa.
    LEROY JG
    Arch Int Pharmacodyn Ther; 1961 Dec; 134():492-6. PubMed ID: 14464270
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of alpha-methyldopa on the metabolism of 5-hydroxytryptamine in rat brain.
    SHARMAN DF; SMITH SE
    J Neurochem; 1962; 9():403-6. PubMed ID: 13911386
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of alpha-methyl-DOPA and alpha-methyl-metatyrosine on the metabolism of norepinephrine and serotonin in vivo.
    HESS SM; CONNAMACHER RH; OZAKI M; UDENFRIEND S
    J Pharmacol Exp Ther; 1961 Nov; 134():129-38. PubMed ID: 13907002
    [No Abstract]   [Full Text] [Related]  

  • 4. [Trial of alpha-methyl-dopa in a case of carcinoidosis].
    GEFFROY Y; CARTIER P; LEMOINE P; FABLET J; MOREAU J; MALANDRIN C; LEGRAND M
    Pathol Biol; 1962 Jan; 10():75-7. PubMed ID: 13897491
    [No Abstract]   [Full Text] [Related]  

  • 5. The pharmacological actions of 3,4-dihydroxyphenyl-alpha-methylalanine (alpha-methyldopa), an inhibitor of 5-hydroxytryptophan decarboxylase.
    SMITH SE
    Br J Pharmacol Chemother; 1960 Jun; 15(2):319-27. PubMed ID: 13832156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic studies in carcinoid syndrome: observations on use of alpha-methyl DOPA, isonicotinic acid hydrazide and selective tryptophan deficiency.
    DAVIS RB; ALEXANDER CS; ADICOFF A
    Metabolism; 1961 Dec; 10():1035-44. PubMed ID: 13883956
    [No Abstract]   [Full Text] [Related]  

  • 7. [Inhibition of serotonin formation by alpha-methyl-DOPA].
    WESTERMANN E; BALZER H; KNELL J
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1958; 234(3):194-205. PubMed ID: 13600388
    [No Abstract]   [Full Text] [Related]  

  • 8. Serotonin synthesis in carcinoid patients. Its inhibition by alpha-methyl-dopa, with measurement of associated increases in urinary 5-hydroxytryptophan.
    SJOERDSMA A; OATES JA; ZALTZMAN P; UDENFRIEND S
    N Engl J Med; 1960 Sep; 263():585-8. PubMed ID: 13831424
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of alpha-methyl DOPA on the metabolism of 5-hydroxythryptamine in brain.
    ROOS BE; WERDINIUS B
    Life Sci (1962); 1963 Feb; 2():92-6. PubMed ID: 13974700
    [No Abstract]   [Full Text] [Related]  

  • 10. ENHANCEMENT BY RESERPINE AND ALPHA-METHYL DOPA OF THE EFFECTS OF D-AMPHETAMINE UPON THE LOCOMOTOR ACTIVITY OF MICE.
    SMITH CB
    J Pharmacol Exp Ther; 1963 Dec; 142():343-50. PubMed ID: 14098331
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of alpha-methyl-3,4-dihydroxyphenylalanine (methyldopa), reserpine and related agents on some vascular responses in the dog.
    STONE CA; ROSS CA; WENGER HC; LUDDEN CT; BLESSING JA; TOTARO JA; PORTER CC
    J Pharmacol Exp Ther; 1962 Apr; 136():80-8. PubMed ID: 13917453
    [No Abstract]   [Full Text] [Related]  

  • 12. [5-Hydroxytryptamine level in the rhombencephalon of mice exposed to high temperatures].
    SOCHANSKI R; SAMEK D
    Acta Physiol Pol; 1962; 13():407-11. PubMed ID: 13914725
    [No Abstract]   [Full Text] [Related]  

  • 13. The neurochemistry of Parkinson's disease: effect of L-dopa therapy.
    Lloyd KG; Davidson L; Hornykiewicz O
    J Pharmacol Exp Ther; 1975 Dec; 195(3):453-64. PubMed ID: 489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vivo decarboxylation of alpha-methyl DOPA and alpha-methyl metatyrosine.
    CARLSSON A; LINDQVIST M
    Acta Physiol Scand; 1962 Jan; 54():87-94. PubMed ID: 13876658
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of alpha-methyl DOPA and some other decarboxylase inhibitors on brain 5-hydroxtryptamine.
    DRAIN DJ; HORLINGTON M; LAZARE R; POULTER GA
    Life Sci (1962); 1962 Mar; 1():93-7. PubMed ID: 13887715
    [No Abstract]   [Full Text] [Related]  

  • 16. Alpha methyl dopa in the treatment of hypertension.
    DOYLE A; TREVAKS G
    Med J Aust; 1962 Jul; 49(2)():55-6. PubMed ID: 13887654
    [No Abstract]   [Full Text] [Related]  

  • 17. [The effect of intravenously administered DOPA on the blood pressure in pretreated alpha-methyl-DOPA hypertensives. Studies on the blood pressure-lowering mechanism of alpha-methyl-DOPA].
    SCHAER H; ZIEGLER WH
    Klin Wochenschr; 1962 Sep; 40():959-62. PubMed ID: 13976633
    [No Abstract]   [Full Text] [Related]  

  • 18. [Value of alpha-methyl-dopa for the treatment of chronic hypertension].
    ARNOLD OH
    Dtsch Med Wochenschr; 1962 Apr; 87():844-8. PubMed ID: 13862447
    [No Abstract]   [Full Text] [Related]  

  • 19. Febrile reactions to L-alpha-methyl-dopa. Report of three cases.
    LEONARD JW; GIFFORD RW; HUMPHREY DC
    Cleve Clin Q; 1962 Jul; 29():144-7. PubMed ID: 14464072
    [No Abstract]   [Full Text] [Related]  

  • 20. DISSOCIATION OF THE DECARBOXYLASE-INHIBITING AND NOREPINEPHRINE-DEPLETING EFFECTS OF ALPHA-METHYL-DOPA, ALPHA-ETHYL-DOPA, 4-BROMO-3-HYDROXY-BENZYLOXYAMINE AND RELATED SUBSTANCES.
    LEVINE RJ; SJOERDSMA A
    J Pharmacol Exp Ther; 1964 Oct; 146():42-7. PubMed ID: 14221224
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.